Claudia Palena

7PUBLICATIONS
63CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Mechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|May 13, 2025
Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control.

Maria Del Mar Maldonado, Maria Gracia-Hernandez, Loc Huu Le

|Jul 08, 2024
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines.

Jeffrey Schlom, Renee N Donahue, Claudia Palena

|Sep 07, 2023
Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis.

Madeline Dahut, Kristen Fousek, Lucas A Horn

|Jun 28, 2022
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.

Christine M Minnar, Paul L Chariou, Lucas A Horn

Pageof 2

Frequent Collaborators

7 joint publications

Jeffrey Schlom

5 joint publications

James L Gulley

4 joint publications

Renee N Donahue

3 joint publications

Lucas A Horn